Sort
15,273 grants matching “antimicrobial resistance”
MOLECULAR AND STRUCTURAL BASES OF POLYMYXIN RESISTANCE
$204,597Washington University · R01 · FY2002 · AI
Whole Genome Sequencing of N. gonorrhoeae from Non-Culture Based Clinical Specimens to Surveil for Emerging Resistance
$204,572Kyle Jeanne Popovich · Rush University Medical Center · R21 · FY2025 · AI
Functional Screening for Candida Virulence GPI-proteins
$204,562Yue Fu · Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center · R21 · FY2007 · AI
An enabling technology to dissect critical molecular events in bacterial pathogenesis
$204,532Tamara O'Connor · Johns Hopkins University · R21 · FY2018 · AI
Comprehensive characterization of Rv0678 bedaquiline resistance-conferring polymorphisms
$204,479John Zapata Metcalfe · University Of California, San Francisco · R21 · FY2024 · AI
Training in Pediatric Infectious Diseases
$204,454Lisa Saiman · Columbia University Health Sciences · T32 · FY2015 · AI
Randomized Intervention for VesicolUreteral Reflux (RIVUR) Study
$204,388Ron Keren · Children'S Hosp Of Philadelphia · U01 · FY2011 · DK
Toolbox for Tuberculosis Drug Development
$204,375Johns Hopkins University · R01 · FY2003 · AI
Exploiting the Salivary Arsenal to Inhibit Diarrheal Disease
$204,375Esther S. Bullitt · Boston University Medical Campus · R21 · FY2022 · AI
Phase I Clinical Trial to Evaluate a Neisseria Gonorrhoeae Therapeutic Candidate
$204,339Michael Cohen-Wolkowiez · Duke University · N01 · FY2016 · AI
SBIR Phase II: A Novel Antimicrobial Polymer for Medical Devices
$204,299Michael Szycher · Sterling Biomedical, Llc · · FY2011 · TIP
Identifying mucin O-glycans in the regulation of Staphylococcus aureus pathogenesis
$204,152Katharina Ribbeck · Massachusetts Institute Of Technology · R21 · FY2022 · AI
MOLECULAR AND FUNCTIONAL ANALYSES OF THE PMRA/PMRB REGULATORY SYSTEM
$204,120Eduardo A. Groisman · Washington University · R01 · FY2010 · AI
Epidemiologic Methods: Resistant Nosocomial Infections
$204,062Harvard University (Sch Of Public Hlth) · R21 · FY2003 · AI
Leveraging Molecular Technologies to Improve Diagnosis and Management of Pediatric Acute Respiratory Illness in Resource-Constrained Settings
$203,759Emily Jane Ciccone · Univ Of North Carolina Chapel Hill · K23 · FY2023 · AI
Training in Pediatric Infectious Diseases
$203,748Lisa Saiman · Columbia University Health Sciences · T32 · FY2018 · AI
Optical property measurement in human abscess cavities for photodynamic therapy treatment planning
$203,742Timothy M Baran · University Of Rochester · R01 · FY2021 · EB
Solving a Multidrug Resistance Puzzle: Complete Loss of Lipooligosaccharide
$203,693Joseph Michael Boll · University Of Texas Arlington · R21 · FY2019 · AI
Leveraging Molecular Technologies to Improve Diagnosis and Management of Pediatric Acute Respiratory Illness in Resource-Constrained Settings
$203,662Emily Jane Ciccone · Univ Of North Carolina Chapel Hill · K23 · FY2025 · AI
Leveraging Molecular Technologies to Improve Diagnosis and Management of Pediatric Acute Respiratory Illness in Resource-Constrained Settings
$203,605Emily Jane Ciccone · Univ Of North Carolina Chapel Hill · K23 · FY2024 · AI
Anti-inflammatory Assay for Cystic Fibrosis
$203,546Rangan Maitra · Research Triangle Institute · R21 · FY2007 · NS
Combatting Bladder Cancer by Inducing Epithelial Turnover
$203,510Soman N Abraham · Duke University · R21 · FY2019 · CA
Ultrasensitive Point of Care Antigen Test for Detection of Neisseria Gonorrhoeae Using Plasmonic Flours
$203,504Sumanth Gandra · Washington University · R21 · FY2023 · AI
Mechanism and Spread of Qnr-Mediated Resistance
$203,474David C Hooper · Massachusetts General Hospital · R01 · FY2008 · AI
Development of Novel Ophthalmic Antibiotics
$203,404Rachel A F Wozniak · University Of Rochester · K08 · FY2019 · EY